Thema: US68403P2039
ORMP, US68403P2039
money-2724245_1920.jpg - Foto: THN
Oramed Pharmaceuticals stock at EUR 3.78 in late quote
Oramed Pharmaceuticals stock is shown in a late-session Lang & Schwarz snapshot. The quote provides a dated euro reference for investors tracking ORMP.
ad-hoc-news.de, heute 00:19 Uhr
ORMP, US68403P2039
Barron's lists USD 7.00 target for Oramed Pharmaceuticals ...
Oramed will report Q3 earnings on November 16, 2026. ORMP stock costs EUR 3.73 on October 20, 2026 at 6:30 p.m. CEST at Lang & Schwarz.
ad-hoc-news.de, 20.10.26 18:33 Uhr
ORMP, US68403P2039
Barron's lists USD 7.00 target for Oramed Pharmaceuticals ...
Valuation was 0.99 on October 16, 2026. Oramed Pharmaceuticals stock costs USD 4.07 on October 16, 2026, down 2.63 percent versus the Nasdaq prior close.
ad-hoc-news.de, 17.10.26 21:01 Uhr
ORMP, US68403P2039
Oramed Pharmaceuticals schedules November 12 results for ...
Oramed's P/E was 1.01 on October 15, 2026. Oramed Pharmaceuticals stock was EUR 3.72 on October 15, 2026, unchanged versus Tradegate close.
ad-hoc-news.de, 15.10.26 20:57 Uhr
ORMP, US68403P2039
Oramed Pharmaceuticals stock fell 3.74 percent as targets ...
Fintel set Oramed's average one-year target at USD 7.14 on September 15, 2026, up from USD 6.38. The Nasdaq quote reached USD 4.38 on October 6.
ad-hoc-news.de, 07.10.26 07:27 Uhr
ORMP, US68403P2039
Oramed officer proposes USD 140,100 sale of Oramed Pharmaceuticals ...
The filing covers 30,000 shares under a March 30, 2026 trading plan. Oramed Pharmaceuticals stock costs EUR 3.99 on October 2, 2026 versus EUR 3.98.
ad-hoc-news.de, 02.10.26 12:07 Uhr
Oramed, Shares
Oramed Shares Face Pressure Amid Strategic Pivot and Dividend ...
Oramed US68403P2039
boerse-global.de, 23.01.26 13:54 Uhr
Oramed, Announces
Oramed Announces Shareholder Capital Return Following Strategic ...
Oramed US68403P2039
boerse-global.de, 10.01.26 13:41 Uhr
Oramed’s, Corporate
Oramed’s Corporate Defense: A Biotech’s Battle for Autonomy ...
